Prognostic model for distant metastasis in locally advanced nasopharyngeal carcinoma after concurrent chemoradiotherapy

被引:14
|
作者
Chen, Chuangzhen [1 ]
Chen, Siqia [1 ,2 ]
Le, Quynh-Thu [3 ]
Chen, Jianzhou [1 ]
Chen, Zhijian [1 ]
Li, Dongsheng [1 ]
Zhou, Mingzhen [1 ]
Li, Derui [1 ]
机构
[1] Shantou Univ Med Coll, Dept Radiat Oncol, Canc Hosp, Shantou 515031, Guangdong, Peoples R China
[2] Shantou Univ Med Coll, Dept Neurol, Affiliated Hosp 1, Shantou 515031, Guangdong, Peoples R China
[3] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
nasopharyngeal cancer; radiotherapy; distant metastasis; prognosis; model; INTENSITY-MODULATED RADIOTHERAPY; RADIATION-THERAPY; POOR-PROGNOSIS; CHEMOTHERAPY; CANCER; SYSTEM; LDH;
D O I
10.1002/hed.23583
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundA prognostic model should be established for distant metastasis in locally advanced nasopharyngeal carcinoma (NPC) after concurrent chemoradiotherapy (CCRT). MethodsPatients with locally advanced NPC who received CCRT were divided into a construction set (230 patients) and a validating set (115 patients). The constructed index was derived on the former and then tested on the latter. ResultsThe prognostic score was defined as the number of adverse prognostic factors: age >45, N-3 category, hemoglobin <11.0 g/dL and lactate dehydrogenase 240 U/L. The score predicted the 5-year distant metastasis-free survival as follows: 0, 91%; 1, 74%; 2, 51%; and 3, 12%. In the validating set, the observed 5-year distant metastasis-free survival of these 4 groups with scores of 0, 1, 2, 3, or higher were 81%, 68%, 47%, and 15%, respectively. ConclusionThe established model might be useful for predicting the risk of distant metastasis in patients with locally advanced NPC who underwent CCRT and may identify the patients' need for intensified adjuvant chemotherapy. (c) 2014 Wiley Periodicals, Inc. Head Neck37: 209-214, 2015
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [1] The role of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma
    Lee, K.
    Hee, S.
    Wee, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S424 - S425
  • [2] Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
    He, Xia-Yun
    Hu, Chao-Su
    Ying, Hong-Mei
    Wu, Yong-Ru
    Zhu, Guo-Pei
    Liu, Tai-Fu
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2010, 267 (05) : 773 - 778
  • [3] Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
    Xia-Yun He
    Chao-Su Hu
    Hong-Mei Ying
    Yong-Ru Wu
    Guo-Pei Zhu
    Tai-Fu Liu
    [J]. European Archives of Oto-Rhino-Laryngology, 2010, 267 : 773 - 778
  • [4] Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone on locally advanced nasopharyngeal carcinoma
    Liu, H.
    Ding, X. R.
    Song, Y. Q.
    Jiang, C.
    Zhong, X. M.
    Hui, H. X.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06): : 2115 - 2119
  • [5] Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
    Xu, Guoqiang
    Wang, Qiaoli
    Wu, Xingrao
    Lv, Chunyan
    Zeng, Guilin
    Xue, Zhihong
    Cao, Ruixue
    Zhang, Nan
    Xiong, Wei
    Huang, Qin
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [6] Induction and concurrent chemoradiotherapy with cetuximab for patients with locally advanced nasopharyngeal carcinoma.
    Ho, G. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis
    Liu, Zhi-gang
    Zhao, Yu
    Tang, Jiao
    Zhou, Yu-juan
    Yang, Wen-juan
    Qiu, Yan-fang
    Wang, Hui
    [J]. ONCOTARGET, 2016, 7 (17) : 24429 - 24435
  • [8] neo adjuvant chemotherapy followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma
    Abdou, Sara
    Benzerouale, Ouail
    El Gueddari, Rania
    Taouchikht, Mouna
    Fares, Houda
    Hassnaoui, Imane
    Ngbwa, Edith Tatiana
    Nouni, Karima
    Lachgar, Amine
    Elkacemi, Hanan
    Kebdani, Tayeb
    Hassouni, Khalid
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S249 - S250
  • [9] Efficacy of nimotuzumab added to concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma
    Wu, Sangang
    Wang, Runjie
    Yu, Yifeng
    Zhou, Ping
    Lian, Chenlu
    Wang, Jun
    Lin, Qin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
    Setakornnukul, Jiraporn
    Thephamongkhol, Kullathorn
    [J]. BMC CANCER, 2018, 18